Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroadaptations to antipsychotic drugs: Insights from pre-clinical and human post-mortem studies
Davide Amato, Clare L. Beasley, Margaret Hahn, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 76, pp. 317-335
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Social brain, social dysfunction and social withdrawal
Stefano Porcelli, Nic J.A. van der Wee, Steven van der Werff, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 97, pp. 10-33
Open Access | Times Cited: 321
Brain microglia in psychiatric disorders
Valeria Mondelli, Anthony C. Vernon, Federico Turkheimer, et al.
The Lancet Psychiatry (2017) Vol. 4, Iss. 7, pp. 563-572
Open Access | Times Cited: 247
Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects
Spyridon Siafis, Dimitrios Tzachanis, Myrto Samara, et al.
Current Neuropharmacology (2017) Vol. 16, Iss. 8, pp. 1210-1223
Open Access | Times Cited: 132
The emerging tale of microglia in psychiatric disorders
Reza Rahimian, Marina Wakid, Liam Anuj O’Leary, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 1-29
Closed Access | Times Cited: 81
Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability
Davide Amato, Anthony C. Vernon, Francesco Papaleo
Neuroscience & Biobehavioral Reviews (2017) Vol. 85, pp. 146-159
Open Access | Times Cited: 67
Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
Davide Amato, Anna Kruyer, Anne‐Noël Samaha, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 45
Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia
N. А. Shnayder, Aiperi K. Khasanova, Anna Strelnik, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11324-11324
Open Access | Times Cited: 24
Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System
Ayushi Anna Dinesh, Juned Islam, Javad Khan, et al.
CNS Drugs (2020) Vol. 34, Iss. 12, pp. 1229-1251
Closed Access | Times Cited: 34
The interaction network and potential clinical effectiveness of dimensional psychopathology phenotyping based on EMR: a Bayesian network approach
Jianqing Qiu, Ting Zhu, Ke Qin, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Detecting a potential safety signal of antidepressants and type 2 diabetes: a pharmacovigilance‐pharmacodynamic study
Spyridon Siafis, Georgios Papazisis
British Journal of Clinical Pharmacology (2018) Vol. 84, Iss. 10, pp. 2405-2414
Open Access | Times Cited: 33
Antipsychotics cause reversible structural brain changes within one week
Pierluigi Selvaggi, Martin Osugo, Uzma Zahid, et al.
Neuropsychopharmacology (2025)
Closed Access
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables
Andrea de Bartolomeis, Emiliano Prinzivalli, Gemma Callovini, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 81, pp. 356-366
Closed Access | Times Cited: 31
Short-term mechanisms influencing volumetric brain dynamics
Nikki Dieleman, Huiberdina L. Koek, Jeroen Hendrikse
NeuroImage Clinical (2017) Vol. 16, pp. 507-513
Open Access | Times Cited: 30
Orbitofrontal-Striatal Structural Alterations Linked to Negative Symptoms at Different Stages of the Schizophrenia Spectrum
Matthias Kirschner, André Schmidt, Benazir Hodzic-Santor, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 3, pp. 849-863
Open Access | Times Cited: 27
Accumbens D2-MSN hyperactivity drives antipsychotic-induced behavioral supersensitivity
Anna Kruyer, Jeffrey Parrilla-Carrero, Courtney Powell, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 11, pp. 6159-6169
Open Access | Times Cited: 22
Pharmacotherapy of schizophrenia: Mechanisms of antipsychotic accumulation, therapeutic action and failure
Daria Chestnykh, Davide Amato, Johannes Kornhuber, et al.
Behavioural Brain Research (2021) Vol. 403, pp. 113144-113144
Closed Access | Times Cited: 21
Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia
Andrea de Bartolomeis, Mariateresa Ciccarelli, Giuseppe De Simone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5945-5945
Open Access | Times Cited: 8
Normalizing the Abnormal: Do Antipsychotic Drugs Push the Cortex Into an Unsustainable Metabolic Envelope?
Federico Turkheimer, Pierluigi Selvaggi, Mitul A. Mehta, et al.
Schizophrenia Bulletin (2019) Vol. 46, Iss. 3, pp. 484-495
Open Access | Times Cited: 24
Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients
Helle G. Andersen, Jayachandra M. Raghava, Claus Svarer, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 19
Emerging Developments in Human Induced Pluripotent Stem Cell-Derived Microglia: Implications for Modelling Psychiatric Disorders With a Neurodevelopmental Origin
Bjørn Hanger, Amalie C.M. Couch, Lawrence Rajendran, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 19
Reversal of haloperidol-induced orofacial dyskinesia and neuroinflammation by isoflavones
Natália Fernandes Mezzomo, Izaviani da Silva Schmitz, Valtieri Bortoluzzi de Lima, et al.
Molecular Biology Reports (2021) Vol. 49, Iss. 3, pp. 1917-1923
Open Access | Times Cited: 13
Chronic oral treatment with risperidone impairs recognition memory and alters brain-derived neurotrophic factor and related signaling molecules in rats
Indrani Poddar, Patrick M. Callahan, Caterina M. Hernandez, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 189, pp. 172853-172853
Closed Access | Times Cited: 13
Effects of chronic antipsychotic drug exposure on the expression of Translocator Protein and inflammatory markers in rat adipose tissue
Anita Calevro, Marie-Caroline Côtel, Sridhar Natesan, et al.
Psychoneuroendocrinology (2018) Vol. 95, pp. 28-33
Open Access | Times Cited: 14
Systemic neurotransmitter responses to clinically approved and experimental neuropsychiatric drugs
Hamid R. Noori, Lewis Mervin, Vahid Bokharaie, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Pharmacological interaction of Galphimia glauca extract and natural galphimines with Ketamine and Haloperidol on different behavioral tests
Mayra Alejandra Santillan‐Urquiza, Maribel Herrera‐Ruiz, Alejandro Zamilpa, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 103, pp. 879-888
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top